What is included in the long-term monitoring of lymphomas, endocrine, mesenchymal, and other rare tumors of the mediastinum?

Updated: Feb 16, 2021
  • Author: Mary C Mancini, MD, PhD, MMM; Chief Editor: John Geibel, MD, MSc, DSc, AGAF  more...
  • Print

Patients who undergo resection of benign neoplasms or mediastinal cysts can be monitored for a short time (ie, 3-6 months) postoperatively while wound healing and progression of patient activity are being monitored.

Because of the heterogeneity and the small numbers of malignant tumors found in the mediastinum, no single specific method has been described for the follow-up care of patients who undergo intended curative resection of a malignant neoplasm.

Treatment of mediastinal lymphomas is with chemotherapy, radiotherapy, or both. Follow-up care is conducted according to standard lymphoma protocols.

Other malignant mediastinal neoplasms can be observed at appropriate intervals by means of chest radiography and CT, at the discretion of the physician.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!